5-methyltetrahydrofolic acid Cas:134-35-0

We are 5-methyltetrahydrofolic acid CAS:134-35-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


5-methyltetrahydrofolic acid

Synonyms:
MethylFolatemethyl-H4F5-N-Methyl-5,6,7,8-tetrahydrofolic acidMETHYLTETRAHYDROFOLICACIDmethyl-THFn5-CH3-THF5-methyl-(6S)-tetrahydrofolic acid5-methyltetrahydrofolateMETHYL FOLATE(METAFOLIN)(P)5-METHYL-THFN-(5-methyl-5,6,7,8-tetrahydro-pteroyl)-glutamic acid(+-)-L-5-Methyl-5,6,7,8-tetrahydrofolsaeureN5-methyl-THFn5-methyltetrahydrofolate
 
molecular formula: C20H23CaN7O6
Molecular weight: 497.51800
 
Physical Properties:
Density: 1.62 g/cm3
Refractive index: 1.733

 
Specification:
Items of Analysis Standard of Analysis Test Results
Appearance White to yellow powder Complies
Purity ≥97.5% 98.0%
Water ≤12.0% 5.7%
Heavy metal ≤20ppm <20ppm
Residue on ignition ≤0.2% 0.10%
Conclusion Conform to enterprise standard
 
Application:
5-Methyltetrahydrofolic acid is a biologically active form of folic acid. 5-Methyltetrahydrofolic acid is a methylated derivative of tetrahydrofolic acid. 5-Methyltetrahydrofolic acid is the major natural dietary folic acid and is the predominant form of folic acid in plasma and cerebrospinal fluid.
 
Package and Storage:
Storage conditions -20°C
 
 



Market News:It’s official. Nearly two years after the FDA granted conditional approval to Merck’s Keytruda and Eisai’s Lenvima for endometrial cancer, the U.S. regulator has blessed the combination therapy, with no strings attached. 3-phenyl-2-sulfanylidene-5,6,7,8-tetrahydro-1H-[1]benzothiolo[2,3-d]pyrimidin-4-one manufacturer.The green light converts the companies’ accelerated approval to a full approval for endometrial cancer that’s not microsatellite instability high (MSI-H) or mismatch repair deficient (dMMR) and for patients whose tumors have progressed following prior treatment. 2-(Piperidin-3-ylmethyl)-1H-benzimidazole supplier.Capturing multiple aspects of improvement increases confidence that anifrolumab may be an important option for patients.” Methyl 6-chloro-2-methoxynicotinate producer.

Related Products
Product Name
Platinum Cas:7440-06-4 View Details
5,6-Dihydro-3-(4-morpholinyl)-1-(4-nitrophenyl)-2(1H)-pyridinone Cas:503615-03-0 View Details
7-Amino-3-(methoxymethyl)-3-cephem-4-carboxylic Acid View Details
Undecanedioic acid Cas:1852-04-6 manufacturer Potassium Pyruvate Cas:4151-33-1 manufacturer sodium sulfite anhydrous Cas:7757-83-7 manufacturer Ammonium Acetate Cas:631-61-8 manufacturer spathulenol,( )-spathulenol,espatulenol Cas:6750-60-3 manufacturer